Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841833 | 12484183 | 3 | F | 201512 | 20160726 | 20160621 | 20160802 | EXP | US-AMGEN-USASP2016077065 | AMGEN | 49.00 | YR | A | F | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841833 | 12484183 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | 125320 | SOLUTION FOR INJECTION | |||||||||
| 124841833 | 12484183 | 2 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 120 MG, QD | 0 | 120 | MG | QD | ||||||||
| 124841833 | 12484183 | 3 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | 1.25 MG, QWK (50,000UNITS) | 0 | 1.25 | MG | /wk | ||||||||
| 124841833 | 12484183 | 4 | C | ESTRADIOL. | ESTRADIOL | 1 | 2 MG, QD | 0 | 2 | MG | QD | ||||||||
| 124841833 | 12484183 | 5 | C | OXYMORPHONE | OXYMORPHONE | 1 | 5 MG, BID | 0 | 5 | MG | BID | ||||||||
| 124841833 | 12484183 | 6 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 60 MG, Q12H | 0 | 60 | MG | BID | ||||||||
| 124841833 | 12484183 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 1 MG, QD UPTO 3 DAYS AS NEEDED | 0 | 1 | MG | QD | ||||||||
| 124841833 | 12484183 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 100 MG, 1.5 AT BEDTIME | 0 | 100 | MG | |||||||||
| 124841833 | 12484183 | 9 | C | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | 25 MG, 1 TABLET | 0 | 25 | MG | |||||||||
| 124841833 | 12484183 | 10 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, QHS | 0 | 15 | MG | /hr | ||||||||
| 124841833 | 12484183 | 11 | C | LYRICA | PREGABALIN | 1 | 150 MG, QD | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124841833 | 12484183 | 1 | Bone disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124841833 | 12484183 | OT |
| 124841833 | 12484183 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124841833 | 12484183 | Arthropathy | |
| 124841833 | 12484183 | Hip fracture | |
| 124841833 | 12484183 | Intervertebral disc disorder | |
| 124841833 | 12484183 | Off label use | |
| 124841833 | 12484183 | Pneumonia | |
| 124841833 | 12484183 | Sepsis | |
| 124841833 | 12484183 | Swelling face | |
| 124841833 | 12484183 | Tooth abscess | |
| 124841833 | 12484183 | Tooth fracture | |
| 124841833 | 12484183 | Tooth loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124841833 | 12484183 | 1 | 2013 | 0 |